Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish Oil Infusion to Prevent AF After CABG
NCT01175330Phase 3Terminated
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in Atrial fibrillation (AFib), sponsored by E. Meshalkin National Medical Research Centre. Started Aug 2010; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01175330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175330.